JAK1 and type 2 diabetes mellitus: In our murine model of T2D wound healing, both fibroblast-specific SETDB2 knockdown and injection of a commercially available, FDA-approved inhibitor of JAK1,3 improved wound healing and increased myofibroblast gene expression in fibroblasts.